Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Mismetti

Showing results (171-180 of 180) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 180 results.
Haematologica|January 5, 2019
Six months <i>versus</i> two years of oral anticoagulation after a first episode of unprovoked deep-vein thrombosis. The PADIS-DVT randomized clinical trialFrancis Couturaud, Gilles Pernod, Emilie Presles, et al.
Journal of Thrombosis and Haemostasis : JTH|August 26, 2022
Frequency and predictors for chronic thromboembolic pulmonary hypertension after a first unprovoked pulmonary embolism: Results from PADIS studiesAlexandre Fauché, Emilie Presles, Olivier Sanchez, et al.
Anaesthesia, Critical Care & Pain Medicine|June 28, 2025
Anticoagulant management in emergency settings: 2024 guidelines from the French Society of Emergency Medicine (SFMU), the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Working Group on Perioperative Haemostasis (GIHP)Delphine Douillet, Alexandre Godon, Geoffroy Rousseau, et al.
The European Respiratory Journal|January 6, 2018
Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trialCécile Tromeur, Olivier Sanchez, Emilie Presles, et al.
Archives of Cardiovascular Diseases|September 17, 2025
The management of cancer-associated thromboembolism: Proposals from the French multidisciplinary INNOVTE CAT Working GroupIsabelle Mahé, Ygal Benhamou, Asmahane Benmaziane, et al.
The New England Journal of Medicine|March 31, 2025
Extended Reduced-Dose Apixaban for Cancer-Associated Venous ThromboembolismIsabelle Mahé, Marc Carrier, Didier Mayeur, et al.
NEJM Evidence|February 6, 2024
Enoxaparin versus Placebo to Prevent Symptomatic Venous Thromboembolism in Hospitalized Older Adult Medical PatientsDominique Mottier, Philippe Girard, Francis Couturaud, et al.
Anaesthesia, Critical Care & Pain Medicine|October 24, 2024
Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) networkAnne Godier, Dominique Lasne, Gilles Pernod, et al.
Eclinicalmedicine|June 23, 2023
Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trialStéphane Zuily, Benjamin Lefèvre, Olivier Sanchez, et al.
Lancet (London, England)|March 1, 2025
Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trialFrancis Couturaud, Jeannot Schmidt, Olivier Sanchez, et al.
Pageof 18

Showing results (171-180 of 180) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 180 results.
Haematologica|January 5, 2019
Six months <i>versus</i> two years of oral anticoagulation after a first episode of unprovoked deep-vein thrombosis. The PADIS-DVT randomized clinical trialFrancis Couturaud, Gilles Pernod, Emilie Presles, et al.
Journal of Thrombosis and Haemostasis : JTH|August 26, 2022
Frequency and predictors for chronic thromboembolic pulmonary hypertension after a first unprovoked pulmonary embolism: Results from PADIS studiesAlexandre Fauché, Emilie Presles, Olivier Sanchez, et al.
Anaesthesia, Critical Care & Pain Medicine|June 28, 2025
Anticoagulant management in emergency settings: 2024 guidelines from the French Society of Emergency Medicine (SFMU), the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Working Group on Perioperative Haemostasis (GIHP)Delphine Douillet, Alexandre Godon, Geoffroy Rousseau, et al.
The European Respiratory Journal|January 6, 2018
Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trialCécile Tromeur, Olivier Sanchez, Emilie Presles, et al.
Archives of Cardiovascular Diseases|September 17, 2025
The management of cancer-associated thromboembolism: Proposals from the French multidisciplinary INNOVTE CAT Working GroupIsabelle Mahé, Ygal Benhamou, Asmahane Benmaziane, et al.
The New England Journal of Medicine|March 31, 2025
Extended Reduced-Dose Apixaban for Cancer-Associated Venous ThromboembolismIsabelle Mahé, Marc Carrier, Didier Mayeur, et al.
NEJM Evidence|February 6, 2024
Enoxaparin versus Placebo to Prevent Symptomatic Venous Thromboembolism in Hospitalized Older Adult Medical PatientsDominique Mottier, Philippe Girard, Francis Couturaud, et al.
Anaesthesia, Critical Care & Pain Medicine|October 24, 2024
Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) networkAnne Godier, Dominique Lasne, Gilles Pernod, et al.
Eclinicalmedicine|June 23, 2023
Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trialStéphane Zuily, Benjamin Lefèvre, Olivier Sanchez, et al.
Lancet (London, England)|March 1, 2025
Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trialFrancis Couturaud, Jeannot Schmidt, Olivier Sanchez, et al.
Pageof 18